Why Frizzled Receptors Break the GPCR Rules — Gunnar Schulte

GPCR Signaling Isn't Just at the Plasma Membrane

He Left the Bench to Unlock 800 Receptors - Brian Bender

From Rare Bone Disease to Biased Ligands: Reading PTH1R's Rules | Jakob Höppner

Science Moved His Family Four Times - David E. Gloriam

Can You See Two Proteins Touch? - Michel Bouvier

When the Curve Fits, You Never Forget - Samuel Hoare

Measuring Amylin, Not Calcitonin - Agrawal

Why Your Compound Fails In Vivo - Sam Hoare

Can Intuition Drive Drug Discovery? - Brian Arey part 2

Why the Dose Response Was Bell-Shaped - Brian Arey

He Co-Founded a Company. Never Wanted To. - Chris Tate

They Said Receptors Were Imaginary - Dr Robert J Lefkowitz

Subcellular Regulation of PTH1R Signaling - Dr. Jakob Höppner

Bias Isn't Optional. It's Already There - @TerryPharmacologyCorner & Eurofins DiscoverX

The Time Point Changes Everything - Kevin Pfleger

The GPCR Antibody Problem Nobody Fixed - GeneTex - Alexander Ball & Chia Yi Lin

She Nodded Yes. She Had No Idea. - Elva Zhao

A Receptor That Shouldn't Exist Yet / Beatriz Redondo

Making Drugs You Can Actually See - Eleonora Comeo

Why Chimeric GPCRs Fail When They Shouldn't - Charlotte Crauwels

Why GPCR Medicinal Chemistry Still Runs on Serendipity - Chris Dockendorf

SAR Meets GPCR Structure - Dr. Ken Jacobson & Matteo Pavan

Why Location Beats Activation — Sudarshan Rajagopal

Why GPCR Drugs Stall Before The Clinic — Andrew Tobin

Why Potency Misses the Real Drug Story — Sam Hoare

Can a Beta-2 Agonist Avoid Desensitization?/ Tore Bengtsson

Most GPCR Teams Wait Too Long For Cryo-EM — Giovanna Scapin

When Poly-pharmacology Stopped Being a Dirty Word

The GPCR Nobody Can Drug - Joseph Kim

Bryan Roth on GPCR Molecular Glues and Biased Modulation at the Transducer Interface

Tracing Ligand Bias Through GPCR Allosteric Networks

Why Imaging the GLP-1 Receptor in Native Tissue Was Harder Than We Thought

Studying GPCR Pharmacology in Patient-Derived iPSC Models - Terry Hebert

Adenosine Receptor Ligand Design: Ken Jacobson on A3 Agonists & GPCR Pharmacology

GLP-1 Receptor Biology: From Incretin Signaling to Metabolic Therapeutics

Unconventional Ligands in GPCR Drug Discovery: Prodrugs, Biologics, and Beyond | #GPCRMasterclass

Exploitable GPCR Ligand Behaviors: From Dimerization to Location Bias | #GPCRMasterclass

Drug Diffusion & Tissue Barrier-GPCR Therapeutics: Practical Impact on Drug Design #GPCRMasterclass

Blood, Mating & GPCRs: Why Mosquitoes Hunt You | Laura Duvall 182

GPCR Ligand Kinetics: Real-World Impact for Drug Discovery | #GPCRMasterclass

Quantifying Efficacy and Pathway Bias in GPCR Pharmacology with Dr. Terry Kenakin | #GPCRMasterclass

Allosteric Modulation in GPCRs: Mechanistic Differences and Therapeutic Impact | #GPCRMastreclass

Measuring GPCR Antagonist Affinity: Models, Pitfalls, and Practical Solutions | #GPCRMasterclass

Signaling Bias in GPCRs: Practical Tools for Interpretation and Drug Discovery | #GPCRMasterclass

Advanced Approaches to Quantifying Ligand Binding and Affinity in GPCR Systems | #GPCRMasterclass

GPCR Drug Discovery: Strategies from Target Selection to Lead Optimization | #GPCRMasterclass

Advanced GPCR Data Analysis: Operational Model and Biased Agonism | #GPCRMasterclass

Allosteric Modulation and GPCR Flexibility: Rethinking Drug Discovery | #GPCRMasterclass

Advanced Allosteric Modulation and Kinetics in GPCR Drug Discovery | #GPCRMasterclass

How Lipid Rafts Influence GPCR Signaling | Keyvan Sedaghat 181

Orthosteric Antagonism: Understanding Kinetics, Equilibrium & Binding for GPCRs | #GPCRMasterclass

Optimizing GPCR Functional Assays: Navigating Context, Kinetics & Sensitivity | #GPCRMasterclass

Beyond Signaling: How Agonists Shape GPCR Receptor States | #GPCRMasterclass

Concentration & Response: Practical Analysis and Avoiding Artifacts in Pharmacology #GPCRMasterclass

Decoding Drug Action: Affinity, Efficacy, Allostery, and Kinetics | #GPCRMasterclass

GPCR Assay Strategy, Bias, and Translational Drug Discovery | Martin Marro 180

Scaling GLP-1 Receptor Tools Through Collaboration | Dr. GPCR Podcast 179

Dr. Gregory Tall / Dr. GPCR Podcast 125

Dr. Françoise Bachelerie / Dr. GPCR Podcast 126